These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7848483)

  • 1. Low-molecular-weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting.
    London NJ; Varty K; Thompson M; Sayers RD; Bell PR
    Lancet; 1994 Dec; 344(8936):1571-2. PubMed ID: 7848483
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting.
    Edmondson RA; Cohen AT; Das SK; Wagner MB; Kakkar VV
    Lancet; 1994 Oct; 344(8927):914-8. PubMed ID: 7934346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial.
    McCollum C; Alexander C; Kenchington G; Franks PJ; Greenhalgh R
    J Vasc Surg; 1991 Jan; 13(1):150-61; discussion 161-2. PubMed ID: 1987387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
    van der Meer J; Brutel de la Rivière A; van Gilst WH; Hillege HL; Pfisterer M; Kootstra GJ; Dunselman PH; Mulder BJ; Lie KI
    J Am Coll Cardiol; 1994 Nov; 24(5):1181-8. PubMed ID: 7930237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dipyridamole and aspirin on vein graft patency after coronary bypass operations.
    Chesebro JH
    Thromb Res Suppl; 1990; 12():5-10. PubMed ID: 2082487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of aspirin, dipyridamole and warfarin in femorodistal reconstruction: long-term results.
    Rosenthal D; Mittenthal MJ; Ruben DM; Jones DH; Estes JW; Stanton PE; Lamis PA
    Am Surg; 1987 Sep; 53(9):477-81. PubMed ID: 3631756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Debatable Choice of Iliac Inflow Source for Redo Femoropopliteal and Infrapopliteal Bypass.
    Gabrielli R; Ciocca F; Dante A; Musilli A; Maiorano M; Ventura M
    Ann Vasc Surg; 2018 Oct; 52():316.e15-316.e19. PubMed ID: 29886210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
    van der Meer J; Hillege HL; Kootstra GJ; Ascoop CA; Mulder BJ; Pfisterer M; van Gilst WH; Lie KI
    Lancet; 1993 Jul; 342(8866):257-64. PubMed ID: 8101300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
    Lumsden AB; Morrissey NJ;
    J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients.
    Monaco M; Di Tommaso L; Pinna GB; Lillo S; Schiavone V; Stassano P
    J Vasc Surg; 2012 Jul; 56(1):96-105. PubMed ID: 22551909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of dipyridamole in addition to low dose aspirin in the prevention of occlusion of coronary artery bypass grafts.
    Agnew TM; French JK; Neutze JM; Whitlock RM; Brandt PW; Kerr AR; Webber BJ; Rutherford JD
    Aust N Z J Med; 1992 Dec; 22(6):665-70. PubMed ID: 1489290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antiplatelet and anticoagulant therapy on patency of femorotibial bypass grafts.
    Ala-Kulju K; Ketonen P; Salo J; Sipponen J; Verkkala K; Harjola PT
    J Cardiovasc Surg (Torino); 1990; 31(5):651-5. PubMed ID: 2229166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet drugs improve the patency rates after femoro-popliteal endarterectomy.
    Bollinger A; Brunner U
    Vasa; 1985; 14(3):272-9. PubMed ID: 4050068
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
    Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA
    J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indobufen vs acetylsalicylic acid plus dipyridamole in long-term patency after femoropopliteal bypass.
    D'Addato M; Curti T; Bertini D; Donini I; Ferrero R; Fiorani P; Pellegrino F; Vecchioni R; Visconti W; Zinicola N
    Int Angiol; 1992; 11(2):106-12. PubMed ID: 1402213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suggested treatment protocol for improving patency of femoral-infrapopliteal cryopreserved saphenous vein allografts.
    Buckley CJ; Abernathy S; Lee SD; Arko FR; Patterson DE; Manning LG
    J Vasc Surg; 2000 Oct; 32(4):731-8. PubMed ID: 11013037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC).
    Sanz G; Pajarón A; Alegría E; Coello I; Cardona M; Fournier JA; Gómez-Recio M; Ruano J; Hidalgo R; Medina A
    Circulation; 1990 Sep; 82(3):765-73. PubMed ID: 2203555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of using composite bypass grafts with infragenicular distal anastomosis].
    Pokrovskiĭ AV; Iakhontov DI
    Angiol Sosud Khir; 2014; 20(2):140-7. PubMed ID: 24961336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of problems related to the occluded femoro-distal bypass.
    Harris PL
    Acta Chir Scand Suppl; 1987; 538():125-31. PubMed ID: 3477913
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of antiaggregational therapy on the long-term patency of the femoropopliteal/crural bypass].
    Vasić B; Maglajlić-Djukić S; Gojnić M; Stanković S
    Srp Arh Celok Lek; 2012; 140(1-2):29-34. PubMed ID: 22462344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.